Drug-Resistant Pathogens Can Take Advantage Of COVID-Related Disruptions To Standard IPC Practices, Case Report Shows
December 03, 2020
CIDRAP (12/2, Dall) reports, “A case report from a New Jersey hospital highlights how drug-resistant pathogens can take advantage of COVID-related disruptions to standard infection and prevention control (IPC) practices.” In a paper published “in Morbidit...